Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: |
Title | Drugs and Cell Therapies in |
Description | Skip to main navigation menu Skip to about the journal Skip to the current issue Skip to site footer Open Menu Drugs and Cell Therapies in Hematology Drug |
Keywords | N/A |
WebSite | dcth.org |
Host IP | 184.168.97.124 |
Location | United States |
Site | Rank |
US$276,872
Last updated: 2023-05-08 07:01:58
dcth.org has Semrush global rank of 38,228,170. dcth.org has an estimated worth of US$ 276,872, based on its estimated Ads revenue. dcth.org receives approximately 31,947 unique visitors each day. Its web server is located in United States, with IP address 184.168.97.124. According to SiteAdvisor, dcth.org is safe to visit. |
Purchase/Sale Value | US$276,872 |
Daily Ads Revenue | US$256 |
Monthly Ads Revenue | US$7,668 |
Yearly Ads Revenue | US$92,007 |
Daily Unique Visitors | 2,130 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
dcth.org. | A | 7198 | IP: 184.168.97.124 |
dcth.org. | NS | 3600 | NS Record: ns23.domaincontrol.com. |
dcth.org. | NS | 3600 | NS Record: ns24.domaincontrol.com. |
Skip to main navigation menu Skip to about the journal Skip to the current issue Skip to site footer Open Menu Drugs and Cell Therapies in Hematology Drugs and Cell Therapies in Hematology Home Editorial Team Current Archives Submission About About the Journal Submissions Privacy Statement Search Register Login About the Journal Drugs and Cell Therapies in Hematology eISSN: 2281-4876 Editor-in-Chief: Geraldino Trevisano Italy The impressive development in recent years of new drugs in the field of hematology, the very promising results of cellular therapy, and the confirmed and expanded role of hematopoietic stem cells transplantation, leaded us to found a new scientific journal entitled “DCTH - Drugs and Cells Therapies in Hematology”. The aim of this journal is to publish peer-reviewed papers on different issues of experimental and clinical hematology preferentially dealing with, though not limited to, experimental, pre-clinical and clinical studies with conventional and novel drugs |
HTTP/1.1 302 Found Date: Fri, 29 Oct 2021 13:56:44 GMT Server: Apache Location: https://www.dcth.org/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 302 x-powered-by: PHP/7.3.31 set-cookie: OJSSID=87f8d93e8124705422918d4ce6a0a6b9; path=/; domain=www.dcth.org location: https://www.dcth.org/index.php/journal content-type: text/html; charset=UTF-8 date: Fri, 29 Oct 2021 13:56:45 GMT server: Apache HTTP/2 200 x-powered-by: PHP/7.3.31 cache-control: no-store set-cookie: OJSSID=be349ffc4b1c5a396f3886ee70ee4398; path=/; domain=www.dcth.org content-type: text/html; charset=utf-8 date: Fri, 29 Oct 2021 13:56:45 GMT server: Apache |
Domain Name: DCTH.ORG Registry Domain ID: D402200000016537250-LROR Registrar WHOIS Server: whois.godaddy Registrar URL: http://www.whois.godaddy.com Updated Date: 2021-06-14T03:51:37Z Creation Date: 2021-04-14T16:14:39Z Registry Expiry Date: 2023-04-14T16:14:39Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: +1.4806242505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Registrant Organization: Domains By Proxy, LLC Registrant State/Province: Arizona Registrant Country: US Name Server: NS24.DOMAINCONTROL.COM Name Server: NS23.DOMAINCONTROL.COM DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form https://www.icann.org/wicf/) >>> Last update of WHOIS database: 2021-09-17T03:04:27Z <<< |